Clinical Trial Update: Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study of cabazitaxel in urothelial carcinoma patients after platinum-based chemotherapy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-09